Table 4 Laboratory and clinical markers—safety indicators
From: Dapagliflozin in peritoneal dialysis patients: a pilot study evaluating peritoneal membrane function
Pre-treatment Regular Dialysis | Post-treatment SGLT-2 Dialysis | P-value* | |
|---|---|---|---|
Median [Range] (Missing) | |||
Systolic Blood Pressure | 125 [70–179] | 112 [80–193] | 0.904 |
Diastolic Blood Pressure | 77.5 [40–90] | 72 [52–95] | 0.481 |
Serum Creatinine | 10.55 [6.40–17.39] | 10.89 [6.06- 17.98] | 0.135 |
Serum Bicarbonate | 21.70 [18.40–25.30] | 21.55 [16.30–26.10] | 0.936 |
Serum Uric Acid | 6.40 [4.10–9.30] | 6.70 [3.90–8.50] | 0.190 |
Serum Blood Urea Nitrogen | 47.70 [30.10–99.90] | 46.60 [33.40–100] | 0.211 |
Serum Albumin | 3.57 [2.25–4.89] | 3.43 [2.62–4.99] | 0.390 |